What would it take to convince you to donate? A survey study of the relationship between motivators, barriers, and payment for whole blood, plasma, and platelet donation.
monetary payment
plasma donation
platelet donation
whole blood donation
Journal
Transfusion
ISSN: 1537-2995
Titre abrégé: Transfusion
Pays: United States
ID NLM: 0417360
Informations de publication
Date de publication:
06 2022
06 2022
Historique:
revised:
30
03
2022
received:
21
02
2022
accepted:
30
03
2022
pubmed:
26
4
2022
medline:
14
6
2022
entrez:
25
4
2022
Statut:
ppublish
Résumé
With growing discussion about blood donor remuneration, the present study examined the level of payment that may be required to convince individuals to engage in whole blood, plasma, and platelet donations. Anonymous online surveys were completed by a college sample [n = 490; 76.9% female; Mean Age = 20.3 (SD = 4.9) years; 32.9% whole blood donors] and a ResearchMatch sample [n = 323; 70.6% female; Mean Age = 50.7 (SD = 16.6) years; 82.7% whole blood donors]. Level of payment needed to motivate whole blood, plasma, and platelet donation was examined as a function of donation history, sample, and gender. In addition, path analyses examined associations between donation motivators, barriers, and payment level. Across all types of donation, history of whole blood donation was related to a greater willingness to donate without payment. At the same time, however, sizeable portions of prior donors indicated that monetary payment would convince them to donate whole blood (24%), plasma (51%), or platelets (57%). Across all types of donation, donation-related barriers (i.e., anxiety, fear) were indirectly related to higher payment levels via lower self-efficacy and more negative donation attitudes. Donation-related motivators (i.e., warm glow, regret, and altruism) were indirectly related to lower payment levels via higher self-efficacy and more positive donation attitudes. Despite reporting a strong commitment to nonremunerated blood donation, many respondents with and without a history of blood donation indicated that money would convince them to engage in whole blood, plasma, and platelet donation.
Sections du résumé
BACKGROUND
With growing discussion about blood donor remuneration, the present study examined the level of payment that may be required to convince individuals to engage in whole blood, plasma, and platelet donations.
STUDY DESIGN AND METHODS
Anonymous online surveys were completed by a college sample [n = 490; 76.9% female; Mean Age = 20.3 (SD = 4.9) years; 32.9% whole blood donors] and a ResearchMatch sample [n = 323; 70.6% female; Mean Age = 50.7 (SD = 16.6) years; 82.7% whole blood donors]. Level of payment needed to motivate whole blood, plasma, and platelet donation was examined as a function of donation history, sample, and gender. In addition, path analyses examined associations between donation motivators, barriers, and payment level.
RESULTS
Across all types of donation, history of whole blood donation was related to a greater willingness to donate without payment. At the same time, however, sizeable portions of prior donors indicated that monetary payment would convince them to donate whole blood (24%), plasma (51%), or platelets (57%). Across all types of donation, donation-related barriers (i.e., anxiety, fear) were indirectly related to higher payment levels via lower self-efficacy and more negative donation attitudes. Donation-related motivators (i.e., warm glow, regret, and altruism) were indirectly related to lower payment levels via higher self-efficacy and more positive donation attitudes.
CONCLUSION
Despite reporting a strong commitment to nonremunerated blood donation, many respondents with and without a history of blood donation indicated that money would convince them to engage in whole blood, plasma, and platelet donation.
Identifiants
pubmed: 35467768
doi: 10.1111/trf.16886
pmc: PMC9322277
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1251-1260Informations de copyright
© 2022 The Authors. Transfusion published by Wiley Periodicals LLC on behalf of AABB.
Références
Transfusion. 2021 Dec;61(12):3372-3380
pubmed: 34535897
Transfusion. 2021 Apr;61(4):1000-1003
pubmed: 33831224
Transfus Med Rev. 2011 Oct;25(4):317-34
pubmed: 21641767
Transfusion. 2012 Feb;52(2):375-80
pubmed: 21848969
Transfusion. 2008 Jan;48(1):43-54
pubmed: 17894795
Transfusion. 2013 Feb;53(2):315-21
pubmed: 22670781
Transfusion. 2021 Jul;61(7):2107-2115
pubmed: 33904178
Vox Sang. 2014 Feb;106(2):118-26
pubmed: 24117697
Transfusion. 2020 Sep;60 Suppl 4:S1-S16
pubmed: 32930442
Transfusion. 2020 Jun;60 Suppl 3:S138-S141
pubmed: 32478875
Transfusion. 2014 Mar;54(3 Pt 2):918-24
pubmed: 23915025
Transfusion. 2007 Jun;47(6):1006-13
pubmed: 17524090
Transfusion. 2016 Jun;56(6 Pt 2):1636-44
pubmed: 26826054
Transfus Clin Biol. 2017 Sep;24(3):106-109
pubmed: 28645645
Soc Sci Med. 2013 Nov;96:86-94
pubmed: 24034955
Transfusion. 2020 Sep;60(9):1998-2009
pubmed: 32678484
Transfusion. 2020 Jun;60 Suppl 3:S134-S137
pubmed: 31872904
Transfusion. 2021 Jan;61(1):303-312
pubmed: 33098328
Transfusion. 2009 Feb;49(2):320-9
pubmed: 19040598
Transfusion. 2012 Sep;52(9):1889-900
pubmed: 22320456
Transfusion. 2014 Mar;54(3 Pt 2):839-47
pubmed: 24660764
Transfusion. 2001 Feb;41(2):172-8
pubmed: 11239218
Health Serv Res. 2003 Dec;38(6 Pt 1):1579-98
pubmed: 14727789
Eur J Cancer Care (Engl). 2017 Nov;26(6):
pubmed: 26880318
BMC Med Res Methodol. 2015 Oct 05;15:78
pubmed: 26438235
Transfusion. 2018 Jan;58(1):242-254
pubmed: 29106732
Transfusion. 2020 Jul;60(7):1450-1453
pubmed: 32286685
Transfusion. 2003 Jan;43(1):7-16
pubmed: 12519425
Transfusion. 2002 Feb;42(2):216-25
pubmed: 11896338
Transfus Apher Sci. 2008 Apr;38(2):159-66
pubmed: 18331813
Transfusion. 2022 Jun;62(6):1251-1260
pubmed: 35467768
Contemp Clin Trials. 2017 Feb;53:44-51
pubmed: 27979752
Science. 2013 May 24;340(6135):927-8
pubmed: 23704557
Transfus Med Rev. 2008 Jul;22(3):215-33
pubmed: 18572097
Transfusion. 2011 Nov;51(11):2438-44
pubmed: 21575003